goBalto announced the release of Analyze
goBalto,a provider of cloud-based clinical study startup solutions, announced the release of Analyze, a reporting tool that provides a real-time view into clinical operations data.
Analyze provides insight into performance across accounts, portfolios, studies, countries, and sites. Reports can also be shared internally and externally to members of partnering organizations. It features customizable reports, drag and drop visualizations, and interactive dashboards on activities related to clinical study startup.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.